Altered Daytime Fluctuation Pattern of Plasminogen Activator Inhibitor 1 in Type 2 Diabetes Patients with Coronary Artery Disease: A Strong Association with Persistently Elevated Plasma Insulin, Increased Insulin Resistance, and Abdominal Obesity

Human circadian system causes a morning peak in prothrombotic plasminogen activator inhibitor-1 (PAI-1) independent of the sleep/wake cycle

(2013) F. A. J. L. Scheer et al.   BLOOD

PAI-1 and Diabetes: A Journey From the Bench to the Bedside

(2012) D. J. Schneider et al.   DIABETES CARE

In young post-myocardial infarction male patients elevated plasminogen activator inhibitor-1 correlates with insulin resistance and endothelial dysfunction

(2012) Barbara Eržen et al.   HEART AND VESSELS

Metabolic Factors, Adipose Tissue, and Plasminogen Activator Inhibitor-1 Levels in Type 2 Diabetes

(2011) L. Maria Belalcazar et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Circulating adhesion molecules, matrix metalloproteinase-9, plasminogen activator inhibitor-1, and myeloperoxidase in coronary artery disease patients with stable and unstable angina

(2011) Peteris Tretjakovs et al.   CLINICA CHIMICA ACTA

Postprandial hypertriglyceridemia associated with inflammatory response and procoagulant state after a high-fat meal in hypertensive patients

(2010) Ling Liu et al.   CORONARY ARTERY DISEASE

PAI-1 activity, but not fibrinogen or von Willebrand factor, is inversely related to LDL particle size in type 2 diabetes

(2007) Ilse Mertens et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS